pharmaceutical

Conglomerate boosts China's push to revolutionise its health sector by buying US biotech pioneer Dendreon. It complements Sanpower's previous investment in more prosaic health assets.

Zhengzhou Coal Mining Machinery and Fosun Pharmaceutical — both already listed in Shanghai — seek to raise a combined $1 billion through their offerings.

Robust demand from high-quality institutions allows the majority owner to sell more shares than planned in Tempo Scan, an Indonesian pharmaceutical and consumer products company.

Takeda agrees to pay $14 billion for Swiss drug company Nycomed in Japan's largest-ever pharma M&A deal.

Regional finance director Henryady Sudjana explains why the pharmaceutical company Actavis is implementing a centralised regional treasury in Indonesia.

China Nepstar raises $334.1 million after pricing its IPO 20% above the range - the maximum allowed on a US offering.

Inidan drug maker prices deal at low end of tight range in wake of 63% share price surge this year.

Fierce competition for mandate results in deal having to be sold below par.

Pharma company brings unusual structured CB.